Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

38.20
-0.2793-0.73%
Post-market: 38.18-0.0195-0.05%16:10 EDT
Volume:726
Turnover:27.80K
Market Cap:20.05M
PE:- -
High:38.36
Open:38.15
Low:38.15
Close:38.48
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.96
T/O Rate:0.14%
Dividend:0.11
Dividend Rate:0.29%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Guardant Health Loses $245.2 Million Patent Infringement Case

MT Newswires Live
·
Yesterday

Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance

Reuters
·
Yesterday

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Yesterday

Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026

THOMSON REUTERS
·
Yesterday

Twinstrand: Delaware Court Enters Judgment on Aug. 21 in Favor of Co & University of Washington in Patent Infringement Suit Against Guardant Health

THOMSON REUTERS
·
Yesterday

Twinstrand: Under Judgment, Guardant Health Must Provide Co & Uw with Quarterly Accounting of All U.S. Sales of 11 Guardant Health Products & Services

THOMSON REUTERS
·
Yesterday

Twinstrand: Court Preserves 2023 Willful Infringement Verdict & Orders 6% Royalty on Sales of 11 Guardant Health Products & Services

THOMSON REUTERS
·
Yesterday

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Yesterday

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan

TIPRANKS
·
Yesterday

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS
·
Yesterday

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Reuters
·
Yesterday

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
Yesterday

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
Yesterday

Celltrion Seeks Korean Approval for Keytruda Biosimilar CT-P51 After Positive Trial

TIPRANKS
·
Yesterday

AMD Stock Joins Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Yesterday

Hype for Moderna's Cancer Vaccine is Running Ahead of the Math - Heard on the Street

Dow Jones
·
Aug 23

Moderna (MRNA) Posts First Late Stage mRNA Cancer Vaccine Win In Melanoma

Simply Wall St.
·
Aug 23

UnitedHealth Group (UNH) Joins Zacks Strong Buy List As Undervalued Narrative Builds

Simply Wall St.
·
Aug 23